CATHERINE ALMETER: Open Payments
NPI 1003480195 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$132 in 6 payments from 5 companies in 2025. Trend: 2023 $41 · 2024 $256 · 2025 $132
Food & beverage: $132
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $44 |
| Dexcom, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, VOQUEZNA, Ozempic, BREZTRI.
Industry payments across NY — which companies pay providers there.
